Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Business / Bausch + Lomb Dry Eye Survey
Business survey results

Bausch + Lomb Dry Eye Survey

Analysis based on 7 articles · First reported Jul 01, 2026 · Last updated Jul 01, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement of the survey results by Bausch + Lomb Corporation could lead to increased awareness and demand for prescription dry eye treatments, potentially boosting sales for Bausch + Lomb Corporation's relevant products. The positive findings regarding prescription treatment efficacy may also influence investor confidence in Bausch + Lomb Corporation.

Pharmaceuticals Healthcare
Event Summary

Bausch + Lomb Corporation announced new findings from its third annual State of Dry Eye survey, conducted by The Harris Poll in May 2026. The survey of 1,000 dry eye sufferers revealed that dry eye symptoms significantly impact emotional health, including self-confidence, emotional well-being, stress/anxiety, productivity, and mood. The findings also indicated that prescription eye drops lead to substantially greater improvement in these areas compared to over-the-counter products. Additionally, the survey highlighted a lack of awareness among sufferers regarding the association of dry eye symptoms with hormonal changes like menopause and autoimmune conditions.

Key Actions
90 Bausch Health — Bausch & Lomb announced findings
50 The Harris Poll conducted survey Bausch Health — Bausch & Lomb
Entities Involved
subs
Bausch Health — Bausch & Lomb
Bausch + Lomb Corporation announced new findings from its third annual State of Dry Eye survey, highlighting the emotional impact of dry eye and the benefits of prescription treatments, which could positively influence its product sales and market position.
Importance 100.0 Sentiment 30.0
priv
The Harris Poll
The Harris Poll conducted the third annual State of Dry Eye survey on behalf of Bausch + Lomb Corporation, reinforcing its role as a market research provider.
Importance 40.0 Sentiment 10.0
per
Andrew Stewart
Andrew Stewart, president of Global Pharmaceuticals and International Consumer at Bausch + Lomb Corporation, commented on the survey findings, emphasizing the holistic benefits of addressing dry eye symptoms.
Importance 30.0 Sentiment 10.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.